We are live on ! Find out more
ACM

Ashford Capital Management Portfolio holdings

AUM $809M
1-Year Est. Return 35.1%
This Fund
S&P 500
This Quarter Est. Return
+10.63%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.15%
5 Year Est. Return
+109.93%
10 Year Est. Return
+1,281.06%
AUM
$898M
AUM Growth
+$46.6M
Cap. Flow
-$1.9M
Cap. Flow %
-0.21%
Top 10 Hldgs %
37.38%
Holding
117
New
15
Increased
24
Reduced
44
Closed
7

Sector Composition

Rank Sector Weight
1 Technology 23.88%
2 Healthcare 16.79%
3 Financials 11.81%
4 Industrials 8.02%
5 Communication Services 7.86%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GSAT icon
1
Globalstar
GSAT
$10.2B
$51.3M 5.71%
1,409,321
+51,703
+4% +$1.48M
LGND icon
2
Ligand Pharmaceuticals
LGND
$6.02B
$43.3M 4.82%
244,430
-58,097
-19% -$8.64M
ODD icon
3
ODDITY Tech
ODD
$708M
$34.2M 3.81%
548,592
-16,362
-3% -$1.06M
SNEX icon
4
StoneX
SNEX
$8.83B
$31.6M 3.52%
704,799
-108,423
-13% -$4.6M
CLBT icon
5
Cellebrite
CLBT
$3.54B
$31.5M 3.51%
1,700,285
+434,615
+34% +$6.83M
VTI icon
6
Vanguard Total Stock Market ETF
VTI
$654B
$30.4M 3.38%
92,534
-1,058
-1% -$334K
RDVT icon
7
Red Violet
RDVT
$859M
$30.3M 3.38%
580,708
-12,806
-2% -$607K
FNV icon
8
Franco-Nevada
FNV
$41.4B
$28.1M 3.13%
126,252
-11,826
-9% -$2.13M
CVCO icon
9
Cavco Industries
CVCO
$4.39B
$27.9M 3.11%
48,019
-6,954
-13% -$3.4M
SUPN icon
10
Supernus Pharmaceuticals
SUPN
$2.68B
$26.9M 3%
563,718
-10,654
-2% -$429K
HQY icon
11
HealthEquity
HQY
$7.91B
$25.8M 2.87%
271,963
-7,441
-3% -$700K
CSGP icon
12
CoStar Group
CSGP
$11.3B
$23.7M 2.64%
280,738
-10,365
-4% -$916K
AXON
13
Axon Enterprise
AXON
$40.5B
$21.5M 2.39%
29,936
-7,470
-20% -$5.67M
EQIX icon
14
Equinix
EQIX
$107B
$19.1M 2.13%
24,359
-240
-1% -$188K
CPRT icon
15
Copart
CPRT
$25.9B
$18.9M 2.11%
420,349
-13,227
-3% -$623K
AYI icon
16
Acuity Brands
AYI
$9.88B
$18.8M 2.1%
54,637
-1,840
-3% -$587K
SKWD icon
17
Skyward Specialty Insurance
SKWD
$2.45B
$18.5M 2.06%
387,972
-18,060
-4% -$903K
TYL icon
18
Tyler Technologies
TYL
$12.2B
$17.3M 1.93%
33,098
-586
-2% -$329K
BRK.A icon
19
Berkshire Hathaway Class A
BRK.A
$1.07T
$16.6M 1.85%
22
KNSL icon
20
Kinsale Capital Group
KNSL
$7.95B
$16.2M 1.81%
38,175
-1,955
-5% -$886K
CYBR
21
DELISTED
CyberArk
CYBR
$15.8M 1.76%
32,784
-14,419
-31% -$6.19M
UFPT icon
22
UFP Technologies
UFPT
$1.84B
$15.1M 1.68%
75,610
+4,820
+7% +$1.06M
FROG icon
23
JFrog
FROG
$9.71B
$14.6M 1.63%
309,408
-10,390
-3% -$469K
WGS icon
24
GeneDx Holdings
WGS
$1.75B
$14.3M 1.59%
132,456
-39,070
-23% -$4.26M
CWAN
25
DELISTED
Clearwater Analytics
CWAN
$14M 1.56%
777,719
-137,725
-15% -$2.79M

Similar funds

Ashford Capital Management's Q3 2025 Portfolio in Review

As of Q3 2025, Ashford Capital Management held 117 positions worth $898M, up 5.5% from $851M the previous quarter. Its ten largest holdings account for 37% of the portfolio.

Ashford Capital Management's Q3 2025 filing shows 15 new, 24 increased, 44 reduced and 7 closed positions. Its largest new stake was Dutch Bros: 161,390 shares worth $8.45M. The largest sale was Ligand Pharmaceuticals, an estimated $8.64M.

By sector, the portfolio is most concentrated in Technology at 24% of assets, down from 25% a quarter earlier, followed by Healthcare and Financials.

  • Ashford Capital Management's largest Q3 2025 buy was Dutch Bros: 161,390 shares worth $8.45M.
  • Ashford Capital Management added most to Cellebrite in Q3 2025, an estimated $6.83M increase.
  • Ashford Capital Management's biggest Q3 2025 reduction was Ligand Pharmaceuticals, cutting an estimated $8.64M.
  • Ashford Capital Management fully exited Goosehead Insurance in Q3 2025, selling an estimated $2.92M.
  • Ashford Capital Management's ten largest holdings make up 37% of its $898M portfolio in Q3 2025.
  • Ashford Capital Management opened 15 new positions and closed 7 in Q3 2025.
  • Ashford Capital Management's portfolio value rose 5.5% quarter-over-quarter to $898M.

Based on Ashford Capital Management's 13F filing for Q3 2025, filed 14 Nov 2025.